To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: Initial labs revealed high -level C -reactive protein, leukopenia but platelet, coagulation screening

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 3 (PDF)

Found: SARS -CoV-2 (severe acute respiratory syndrome coronavirus 2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 6 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 2 (PDF)

Found: SARS -CoV-2 (severe acute respiratory syndrome coronavirus 2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 4 (PDF)

Found: severe acute respiratory syndrome coronavirus 2 (SARS -CoV-2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 7 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer- BioNTech Coronavirus

Scottish Government Publication (Research and analysis)
Tackling Child Poverty and Social Justice Directorate

Mar. 07 2024

Source Page: Child And Parental Wellbeing: Measuring wellbeing outcomes and understanding their relation with poverty
Document: Child and parental wellbeing: measuring wellbeing outcomes and understanding their relation with poverty (PDF)

Found: SDQ is a validated screening to ol for emotional and behavioural difficulties in children and young

Departmental Publication (Policy paper)
HM Treasury

Mar. 06 2024

Source Page: Spring Budget 2024
Document: Spring Budget 2024 (web) (PDF)

Found: swiftly, providing support worth £373 billion to the economy during the pandemic, including through the Coronavirus